NCT02310178 Obesity Cohort : Medical Follow-up of Severe or Morbid Obese Patients Undergoing Bariatric Surgery
| NCT ID | NCT02310178 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Montpellier |
| Condition | Obesity, Morbid |
| Study Type | INTERVENTIONAL |
| Enrollment | 750 participants |
| Start Date | 2012-05-21 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 750 participants in total. It began in 2012-05-21 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this cohort is to evaluate the follow-up of morbidly obese patients treated by several types of bariatric procedures. In addition, this study could lead to the development of clinical trials on assessment of the bariatric surgery impact.
Eligibility Criteria
Inclusion Criteria: * Only be considered in patients operated and followed at CHU Montpellier with bariatric surgery * Patients treated by bariatric surgery on CHU Montpellier * Agreed to participate to the study by signing an informed consent * Eligible to health insurance Exclusion Criteria: * Unable to follow the patient in the long term (foreign patients, surgical use ...) * Inability to follow in the long run
Contact & Investigator
Frequently Asked Questions
Who can join the NCT02310178 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, studying Obesity, Morbid. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02310178 currently recruiting?
Yes, NCT02310178 is actively recruiting participants. Contact the research team at d-nocca@chu-montpellier.fr for enrollment information.
Where is the NCT02310178 trial being conducted?
This trial is being conducted at Montpellier, France.
Who is sponsoring the NCT02310178 clinical trial?
NCT02310178 is sponsored by University Hospital, Montpellier. The trial plans to enroll 750 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.